Mirae Asset Global ETFs Holdings
HCAT icon

Mirae Asset Global ETFs Holdings’s Health Catalyst HCAT Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40.8K Buy
32,104
+739
+2% +$1.39K ﹤0.01% 2949
2025
Q4 		$75K Sell
31,365
-370
-1% -$1.01K ﹤0.01% 2798
2025
Q3 		$90.4K Buy
+31,735
New +$109K ﹤0.01% 2711
2025
Q2 		– Sell
-36,047
Closed -$163K – 3097
2025
Q1 		$163K Buy
36,047
+2,624
+8% +$13.9K ﹤0.01% 2413
2024
Q4 		$236K Buy
33,423
+1,444
+5% +$11.5K ﹤0.01% 2303
2024
Q3 		$260K Buy
31,979
+2,693
+9% +$19.5K ﹤0.01% 2237
2024
Q2 		$187K Buy
+29,286
New +$188K ﹤0.01% 2289

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return